Skip to main content

Animations

MJFF Publications

1121 - 1130 of 6431 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2023
  • 2023
  • 2022
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202401641
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Cognitive Symptoms in Cross-Sectional Parkinson Disease Cohort Evaluated by Human-in-the-Loop Machine Learning and Natural Language Processing
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000200334
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41592-023-01993-x
    Citation Count: 92
  • Summary Details
    OPEN
    Title: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00468-2
    Citation Count: 36
  • Summary Details
    OPEN
    Title: It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29279
    Citation Count: 20
  • Summary Details
    OPEN
    Title: In vivoreduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac445
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01144-2
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-024-03485-9
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Open-source platform for kinematic analysis of mouse forelimb movement
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2024.103140
    Citation Count: 0
  • Summary Details
    OPEN
    Title: In vivo validation of late‐onset Alzheimer's disease genetic risk factors
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13840
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.